Evidence map›Paper›PMID 38739311›Full record

ArticleBreast cancer research and treatment2024

Characterizing "collateral damage" in men and women with metastatic breast cancer (mBC) from diverse racial and ethnic backgrounds in New York City.

Shoshana M Rosenberg, Caroline Zeng, Anjile An, Shakirah N Ssebyala, Taylor Stein, Gina Lombardo, Desiree Walker, Anne Marie Mercurio, Lauren Elreda, Evelyn Taiwo and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Breast cancer research and treatment, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Shoshana M RosenbergDivision of Epidemiology, Department of Population Health Sciences, Weill Cornell Medicine, 402 E 67st LA-0005, New York, NY, 10065, USA. shr4009@med.cornell.edu.ORCID http://orcid.org/0000-0002-0074-6385
Caroline ZengDivision of General Internal Medicine, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
Anjile AnDivision of Biostatistics, Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.
Shakirah N SsebyalaDivision of General Internal Medicine, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
Taylor SteinDivision of Epidemiology, Department of Population Health Sciences, Weill Cornell Medicine, 402 E 67st LA-0005, New York, NY, 10065, USA.
Gina LombardoDivision of General Internal Medicine, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
Desiree WalkerYoung Survival Coalition, New York, NY, USA.
Anne Marie MercurioPatient Research Advocate, Ponte Vedra Beach, FL, USA.
Lauren ElredaDepartment of Medical Oncology, New York Presbyterian Hospital-Queens Hospital, Queens, NY, USA.
Evelyn TaiwoDepartment of Medical Oncology, Department of Medicine, New York Presbyterian Hospital-Brooklyn Methodist Hospital, Brooklyn, NY, USA.
Dawn L HershmanDivision of Medical Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY, USA.
Laura C PinheiroDivision of Epidemiology, Department of Population Health Sciences, Weill Cornell Medicine, 402 E 67st LA-0005, New York, NY, 10065, USA.

Funding

Optimizing the Delivery of Diabetes Management During Breast Cancer CareK01CA251645 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI PINHEIRO, LAURA C · 2020 to 2024
$819k
National Cancer Institute, United States 1K01CA251645
6 · The paper itself

Abstract

purposePatients from diverse racial, ethnic, and socio-economic backgrounds may be particularly vulnerable to experiencing undue social and financial burdens ("collateral damage") from a metastatic breast cancer (mBC) diagnosis; however, these challenges have not been well explored in diverse populations.

methodsFrom May 2022 to May 2023, English- or Spanish-speaking adults with mBC treated at four New York-Presbyterian (NYP) sites were invited to complete a survey that assessed collateral damage, social determinants of health, physical and psychosocial well-being, and patient-provider communication. Fisher's exact and the Kruskal-Wallis rank-sum tests assessed differences by race and ethnicity.

resultsOf 87 respondents, 14% identified as Hispanic, 28% non-Hispanic Black (NHB), 41% non-Hispanic White (NHW), 7% Asian American Pacific Islander (AAPI), and 10% other/multiracial. While 100% of Hispanic, NHW, and AAPI participants reported stable housing, 29% of NHB participants were worried about losing housing (p = 0.002). Forty-two percent of Hispanic and 46% of NHB participants (vs. 8%, NHW and 0%, AAPI, p = 0.005) were food insecure; 18% of Hispanic and 17% of NHB adults indicated lack of reliable transportation in the last year (vs. 0%, NHW/AAPI, p = 0.033). Participants were generally satisfied with the quality of communication that they had with their healthcare providers and overall physical and mental well-being were modestly poorer relative to healthy population norms.

conclusionsIn our study, NHB and Hispanic mBC patients reported higher levels of financial concern and were more likely to experience food and transportation insecurity compared to NHW patients. Systematically connecting patients with resources to address unmet needs should be prioritized to identify feasible approaches to support economically vulnerable patients following an mBC diagnosis.

Indexed as

Breast NeoplasmsSocioeconomic FactorsAdultAgedEthnicityFemaleHumansMaleMiddle AgedNeoplasm MetastasisNew York CityRacial GroupsSurveys and QuestionnairesCollateral damageDisparitiesFinancial toxicityMetastatic breast cancerPsychosocial well-beingSocial determinants of health

Identifiers

PMID38739311

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.